Bluejay Diagnostics Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
BJDX Nasdaq 8731 https://bluejaydx.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Bluejay Diagnostics Inc

BJDX: 2023 Financial Update - Apr 9th, 2024 10:02 am
Bluejay Diagnostics Announces Closing of $3.5 Million Public Offering - Jan 2nd, 2024 10:58 pm
Bluejay Diagnostics Announces Pricing of $3.5 Million Public Offering - Dec 28th, 2023 1:00 pm
BJDX: SYMON Says: Start the Trial! - Dec 28th, 2023 9:57 am
Bluejay Diagnostics, Inc. Announces Initiation of Multicenter Clinical Study Evaluating Symphony IL-6 in Sepsis Patients (SYMON Study) - Dec 27th, 2023 2:00 pm
Bluejay Diagnostics, Inc. Reports Third Quarter 2023 Financial Results - Nov 9th, 2023 9:05 pm
BJDX: Toray License Renegotiation - Nov 8th, 2023 10:22 am
BJDX: FDA Meeting Confirms Pathway - Aug 28th, 2023 11:59 am
Bluejay Diagnostics Announces $1.59 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules - Aug 25th, 2023 12:00 pm
Bluejay Diagnostics Announces Clinical Update and Reports Second Quarter 2023 Financial Results - Aug 16th, 2023 11:00 am
Bluejay Diagnostics Regains Compliance with Nasdaq Minimum Bid Price Requirement - Aug 10th, 2023 8:05 pm
Will Bluejay Diagnostics (NASDAQ:BJDX) Spend Its Cash Wisely? - Jul 24th, 2023 12:30 pm
Bluejay Diagnostics Announces Reverse Stock Split - Jul 21st, 2023 11:00 am
BJDX: Orchestrating a New Testing Standard - May 31st, 2023 10:36 am
Bluejay Diagnostics Updates Symphony IL-6 Regulatory Strategy - May 19th, 2023 11:00 am
Bluejay Diagnostics Reports First Quarter 2023 Financial Results - May 10th, 2023 11:30 am